查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
宏基因体学市场：全球市场分析及应用、技术、产品和使用者预测 - 高级顾问指南（2026-2030）
市场调查报告书
商品编码
1826003

宏基因体学市场：全球市场分析及应用、技术、产品和使用者预测 - 高级顾问指南（2026-2030）

Metagenomic Markets. Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2026 to 2030
出版日期: | 出版商: Howe Sound Research | 英文 374 Pages | 商品交期: 最快1-2个工作天内

价格

报告概述

无限的成长潜力？颠覆产业格局？毫不夸张地说，宏基因组学检测有望彻底改变医疗治疗。阅读这份全新的研究报告，深入了解宏基因体学。

我们才刚开始了解遗传学在健康和疾病中的作用。这些新知识加上成本的下降，正在催生新型基因检测——一种全新的方法。慢性感染？微生物组和肠道微生物组的秘密，揭开真正的罪魁祸首？宏基因组学将为您揭晓答案。从人体治疗到废水研究，这种新方法正在带来令人惊嘆的答案。一些小小的医学奇蹟正在发生。本报告探讨了宏基因体学的技术、应用、使用者和销售产品类型。报告详细分析了14个国家和5个地区的市场状况。

理解相关术语。辨识课题、机会和陷阱。了解五年成长预测和最终市场预测。

利用最新数据，自信地做出投资决策和估值。

目录

第1章 市场指南

第2章 简介与市场定义

  • 什么是宏基因体学？
  • 市场定义
  • 研究方法
  • 视角：医疗保健支出
  • 染色体、基因和表观遗传学

第3章 市场概要

  • 市场参与者
    • 学术研究机构
    • 诊断测试开发商
    • 测量设备供应商
    • 药品和试剂製造商
    • 病理供应商
    • 独立临床实验室
    • 公共国家/地区实验室
    • 医院实验室
    • 临床实验室
    • 审计机构
    • 认证机构
  • 宏基因体学应用
  • 临床产业结构

第4章 市场趋势

  • 成长促进因素
  • 阻碍成长的要素
  • 测量，自动化，诊断趋势

第5章 总体基因体学的最近趋势

第6章 主要企业的简介

  • BaseClear
  • BGI Genomics Co. Ltd
  • Biome Makers
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • Cantata Bio
  • CosmosID
  • Day Zero Diagnostics.
  • Element Biosciences
  • Fusion Genomics.
  • Genolution
  • Helix
  • Illumina
  • Institute for Metagenomics
  • Karius
  • Metabiomics Corp
  • Metagenomi
  • MetaSUB International Consortium
  • Microbiome Insights
  • MicroGenDx
  • Norgen Biotek Corp.
  • Noscendo
  • Novogene
  • One Codex
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PathoQuest S.A.
  • Promega
  • Qiagen
  • Revvity
  • Second Genome
  • Siemens Healthineers
  • Superfluid Dx
  • Sysmex
  • Takara Bio
  • Zymo Research Corp

第7章 全球市场规模

  • 各国全球市场
  • 各用途全球市场
  • 各技术全球市场
  • 各产品全球市场
  • 各用户全球市场

第8章 各用途市场规模

  • 临床
  • 微生物基因体
  • 农业
  • 产业以及其他

第9章 各技术市场规模

  • 16srRNA
  • 霰弹枪
  • WGS
  • 其他

第10章 各产品市场规模

  • 设备
  • 试剂·套件
  • 软体
  • 服务

第11章 各用户市场规模

  • 学术
  • 临床
  • 医药品
  • 其他

第12章 附录

Report Overview:

Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. ItIs a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.

Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What is Metagenomics?
  • 2.2. Market Definition
    • 2.2.1. Revenue Market Size.
    • 2.2.2. Clinical
    • 2.2.3. Microbiome
    • 2.2.4. Agricultural
    • 2.2.5. Environmental & Other
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare Spending
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Healthcare and Pharmaceuticals
    • 2.4.3. Spending on Diagnostics
    • 2.4.4. Important Role of Insurance for Medical Services
  • 2.5. Chromosomes, Genes and Epigenetics
    • 2.5.1. Chromosomes
    • 2.5.2. Genes
    • 2.5.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Metagenomics Applications
    • 3.2.1. Clinical Metagenomics
    • 3.2.2. Diagnostic Use
    • 3.2.3. Syndromic Multiplex vs. Metagenomic Testing
    • 3.2.4. Antimicrobial Resistance
    • 3.2.5. Managing the Microbiome
    • 3.2.6. Public Health Use
  • 3.3. Clinical Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Approach to Diagnostics
    • 4.1.2. The Aging Effect
    • 4.1.3. The Known and the Unknown
    • 4.1.4. A Research Bonanza
  • 4.2. Factors Limiting Growth
    • 4.2.1. Increased Competition Lowers Price
    • 4.2.2. Lower Costs
    • 4.2.3. Testing usage analysis curtailing growth
    • 4.2.4. Wellness has a downside
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Metagenomics Recent Developments

  • 5.1. Recent Developments
    • 5.1.1. Importance of This Section
    • 5.1.2. How to Use This Section
  • 5.2. iconPCR Used in Metagenomics Discovery
  • 5.3. Mapmygenome acquires Canada's Microbiome Insights
  • 5.4. Hamilton to Partner With Labor Berlin, Claret Bioscience
  • 5.5. Complicated UTIs Using Rapid Metagenomics
  • 5.6. Delve Bio Showing Delivers Greater Diagnostic Yield
  • 5.7. Sewage metagenomics potentially allows surveillance
  • 5.8. Rapid metagenomics to reduce AMR and sepsis
  • 5.9. UK and U.S. Use Metagenomics for Biothreat Assessment
  • 5.10. Phase Genomics Metagenomics Innovation Award
  • 5.11. New Method for Human Gut Assessment
  • 5.12. Metagenomic sequencing Used for Pneumonia Care
  • 5.13. Sepsis Study Shows Metagenomic Clinical Value
  • 5.14. Delve Bio to Develop Metagenomic Sequencing Dx
  • 5.15. Metagenomics Could be a Game-changer
  • 5.16. Model Predicts Millions of Metagenomic Proteins
  • 5.17. Microbiome Analysis May Yield False Results
  • 5.18. Gut microbiome at center of Parkinson's disease
  • 5.19. MicroGenDx, Evvy Partner for Metagenomic Test
  • 5.20. Diagnostic accuracy of metagenomic NGS
  • 5.21. Metagenomics implicates the gut microbiome
  • 5.22. Charities Award $2M for Metagenomic Pathogen Research
  • 5.23. Cost-effective metagenomic HiFi sequencing
  • 5.24. Microbiome Links Uncovered
  • 5.25. Metagenomi Named an Endpoints 11 Winner
  • 5.26. Biotia Raises $8M in Series A Financing

6. Profiles of Key Companies

  • 6.1. BaseClear
  • 6.2. BGI Genomics Co. Ltd
  • 6.3. Biome Makers
  • 6.4. bioMerieux Diagnostics
  • 6.5. Bio-Rad Laboratories, Inc
  • 6.6. Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.7. Cantata Bio
  • 6.8. CosmosID
  • 6.9. Day Zero Diagnostics.
  • 6.10. Element Biosciences
  • 6.11. Fusion Genomics.
  • 6.12. Genolution
  • 6.13. Helix
  • 6.14. Illumina
  • 6.15. Institute for Metagenomics
  • 6.16. Karius
  • 6.17. Metabiomics Corp
  • 6.18. Metagenomi
  • 6.19. MetaSUB International Consortium
  • 6.20. Microbiome Insights
  • 6.21. MicroGenDx
  • 6.22. Norgen Biotek Corp.
  • 6.23. Noscendo
  • 6.24. Novogene
  • 6.25. One Codex
  • 6.26. OraSure Technologies
  • 6.27. Oxford Nanopore Technologies
  • 6.28. Pacific Biosciences
  • 6.29. PathoQuest S.A.
  • 6.30. Promega
  • 6.31. Qiagen
  • 6.32. Revvity
  • 6.33. Second Genome
  • 6.34. Siemens Healthineers
  • 6.35. Superfluid Dx
  • 6.36. Sysmex
  • 6.37. Takara Bio
  • 6.38. Zymo Research Corp

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table - Global Market by Technology
    • 7.3.2. Chart - Technology Share by Year
    • 7.3.3. Chart - Technology Segment Growth Rates
    • 7.3.4. Chart - Technology Segment Share Shifts
    • 7.3.5. Chart - Technology Segment Share Base Year
    • 7.3.6. Chart - Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Product Share by Year
    • 7.4.3. Chart - Product Segment Growth Rates
    • 7.4.4. Chart - Product Segment Share Shifts
    • 7.4.5. Chart - Product Segment Share Base Year
    • 7.4.6. Chart - Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table - Global Market by User
    • 7.5.2. Chart - User Share by Year
    • 7.5.3. Chart - User Segment Growth Rates
    • 7.5.4. Chart - User Segment Share Shifts
    • 7.5.5. Chart - User Segment Share Base Year
    • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Clinical Market
    • 8.1.1. Table Clinical - by Country
    • 8.1.2. Chart - Clinical Growth
  • 8.2. Microbiome Market
    • 8.2.1. Table Microbiome - by Country
    • 8.2.2. Chart - Microbiome Growth
  • 8.3. Agriculture Market
    • 8.3.1. Table Agriculture - by Country
    • 8.3.2. Chart - Agriculture Growth
  • 8.4. Industrial & Other Market
    • 8.4.1. Table Industrial & Other - by Country
    • 8.4.2. Chart - Industrial & Other Growth

9. Market Sizes by Technology

  • 9.1. 16srRNA Market
    • 9.1.1. Table 16srRNA - by Country
    • 9.1.2. Chart - 16srRNA Growth
  • 9.2. Shotgun Market
    • 9.2.1. Table Shotgun - by Country
    • 9.2.2. Chart - Shotgun Growth
  • 9.3. WGS Market
    • 9.3.1. Table WGS - by Country
    • 9.3.2. WGS - Growth
  • 9.4. Other Technology Market
    • 9.4.1. Table Other Technology - by Country
    • 9.4.2. Chart - Other Technology Growth

10. Market Sizes by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits - by Country
    • 10.2.2. Chart - Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software - by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services - by Country
    • 10.4.2. Chart - Services Growth

11. Market Sizes by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic - by Country
    • 11.1.2. Chart - Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical - by Country
    • 11.2.2. Chart - Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical - by Country
    • 11.3.2. Pharmaceutical - Predictive Growth
  • 11.4. Other User Market
    • 11.4.1. Table Other User - by Country
    • 11.4.2. Chart - Other User Growth

12. Appendices

  • 12.1. United States Medicare System: Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: The Base Pairs
  • Table 2: Market Players by Type
  • Table 3: The Different Applications of Metagenomic Testing
  • Table 4: Factors Driving Growth
  • Table 5: Four Factors Limiting Growth
  • Table 6: Seven Key Diagnostic Laboratory Technology Trends
  • Table 7: Global Market by Country
  • Table 8: Global Market by Application
  • Table 9: Global Market by Technology
  • Table 10: Global Market by Product
  • Table 11: Global Market by User
  • Table 12: Clinical Segment by Country
  • Table 13: Microbiome Segment by Country
  • Table 14: Agriculture Segment by Country
  • Table 15: Industrial & Other Segment by Country
  • Table 16 16srRNA Segment by Country
  • Table 17: Shotgun Segment by Country
  • Table 18: WGS Segment by Country
  • Table 19: Other Technology Segment by Country
  • Table 20: Instruments Segment by Country
  • Table 21: Reagents and Kits Segment by Country
  • Table 22: Software Segment by Country
  • Table 23: Services Segment by Country
  • Table 24: Academic Segment by Country
  • Table 25: Clinical Segment by Country
  • Table 26: Pharmaceutical Segment by Country
  • Table 27: Other User Segment by Country
  • Table 28: Clinical Lab Fee Schedule
  • Table 29: The Most Common Assays
  • Table 30: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: DNA Strands and Chromosomes
  • Figure 3: Karyogram of Human Chromosomes
  • Figure 4: Size of Various Genomes
  • Figure 5: The Road to Diagnostics
  • Figure 6: The New Diagnostics
  • Figure 7: The Changing Age of the World Population
  • Figure 8: Health Care Consumption by Age
  • Figure 9: Cancer Incidence - Age at Diagnosis
  • Figure 10: Centralized vs. Decentralized Laboratory Service
  • Figure 11: A Highly Multiplexed Syndromic Testing Unit
  • Figure 12: The Real Cost to Sequence the Human Genome
  • Figure 13: The Codevelopment Process
  • Figure 14: Comparing MDx Diagnostic and Traditional Testing
  • Figure 15: Country Market Shares
  • Figure 16: Application Share by Year
  • Figure 17: Application Segment Growth Rates
  • Figure 18: Segment Share Shifts
  • Figure 19: Application Segment Share Base Year
  • Figure 20: Application Segment Share Final Year
  • Figure 21: Technology Share by Year
  • Figure 22: Technology Segment Growth Rates
  • Figure 23: Technology Segment Share Shifts
  • Figure 24: Technology Segment Share Base Year
  • Figure 25: Technology Segment Share Final Year
  • Figure 26: Product Share by Year
  • Figure 27: Product Segment Growth Rates
  • Figure 28: Product Segment Share Shifts
  • Figure 29: Product Segment Share Base Year
  • Figure 30: Product Segment Share Final Year
  • Figure 31: User Share by Year
  • Figure 32: User Segment Growth Rates
  • Figure 33: User Segment Share Shifts
  • Figure 34: User Segment Share Base Year
  • Figure 35: User Segment Share Final Year
  • Figure 36: Clinical vs. Total Market Growth
  • Figure 37: Microbiome vs. Total Market Growth
  • Figure 38: Agriculture vs. Total Market Growth
  • Figure 39: Industrial & Other vs. Total Market Growth
  • Figure 40 16srRNA vs. Total Market Growth
  • Figure 41: Shotgun vs. Total Market Growth
  • Figure 42: WGS vs. Total Market Growth
  • Figure 43: Other Technology vs. Total Market Growth
  • Figure 44: Instrument vs. Total Market Growth
  • Figure 45: Reagents and Kits vs. Total Market Growth
  • Figure 46: Software vs. Total Market Growth
  • Figure 47: Services vs. Total Market Growth
  • Figure 48: Academic vs. Total Market Growth
  • Figure 49: Clinical vs. Total Market Growth
  • Figure 50: Pharmaceutical vs. Total Market Growth
  • Figure 51: Other User Growth